ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,802.45
-0.42%
Dow Jones
42,080.37
0.34%
US Dollar vs MXN
20.76518
0.25%
Brent Oil
80.45
-0.20%
Bitcoin
91,952.50
-2.68%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Cumulex NV (CLEX) Cotización

Cumulex NV

Cumulex NV (CLEX)

EU
1.32
0.00
(0.00%)
Cerrado 13 Enero 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
1.32
Postura de Compra
0.54
Postura de Venta
1.32
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
0.54 Rango de 52 semanas 1.78
Capitalización de Mercado [m]
580.8k
Precio Anterior
1.32
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
58
Acciones en circulación
440,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.64
Beneficio por acción (BPA)
-0.17
turnover
-
Beneficio neto
-76k

Acerca de Cumulex NV

Sector
Beet Sugar
Industria
Beet Sugar
Sitio web
www.cumulex.be
Sede
Brussels, Brussels-capital Region, Bel
Fundado
-
Cumulex NV is listed in the Beet Sugar sector of the Euronext with ticker CLEX. The last closing price for Cumulex NV was 1.32 €. Over the last year, Cumulex NV shares have traded in a share price range of 0.54 € to 1.78 €.

Cumulex NV currently has 440,000 shares in issue. The market capitalisation of Cumulex NV is 580,800.00 € . Cumulex NV has a price to earnings ratio (PE ratio) of -7.64.

CLEX Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.78144.4444444440.541.320.542201.31636364DE
40.78144.4444444440.541.320.541100.99766345DE
120.217.85714285711.121.350.54580.90270945DE
26-0.03-2.222222222221.351.350.54270.910823DE
52-0.18-121.51.780.54281.02383363DE
156-0.88-402.23.380.54412.01206153DE
260-0.3882-22.72567615031.70824.860.54642.30348857DE

CLEX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cumulex NV?
El precio actual de las acciones de Cumulex NV es 1.32 €
¿Cuántas acciones de Cumulex NV están en circulación?
Cumulex NV tiene 440,000 acciones en circulación
¿Cuál es la capitalización de mercado de Cumulex NV?
La capitalización de mercado de Cumulex NV es EUR 580.8k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cumulex NV?
Cumulex NV ha negociado en un rango de 0.54 € a 1.78 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cumulex NV?
El ratio precio/beneficio de Cumulex NV es -7.64
¿Cuál es la moneda de reporte de Cumulex NV?
Cumulex NV presenta sus resultados financieros en EUR
¿Cuál es el último beneficio anual de Cumulex NV?
El último beneficio anual de Cumulex NV es EUR -76k
¿Cuál es la dirección registrada de Cumulex NV?
La dirección registrada de Cumulex NV es BORDER STREET 7, DIEGEM, BRUSSELS, BRUSSELS-CAPITAL REGION, 1831
¿Cuál es la dirección del sitio web de Cumulex NV?
La dirección del sitio web de Cumulex NV es www.cumulex.be
¿En qué sector industrial opera Cumulex NV?
Cumulex NV opera en el sector BEET SUGAR

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
HYPDSHipay Group DS
0.0024 €
(200.00%)
1.83k
ALCYBCybergun
0.0002 €
(100.00%)
16.61M
BNBSTonner Drones
0.0015 €
(50.00%)
100
ALLPLLepermislibre SA
0.60 €
(50.00%)
27.77k
ALVGVEOM Group
0.16 €
(22.14%)
87.97k
ALTHETheraclion
0.23 €
(-17.86%)
34.88k
MLPACPacte Novation
8.35 €
(-14.80%)
3
ALALOAcheterLouerFR
0.0958 €
(-12.91%)
121.44k
MLVIRVirtualware 2007 SA
7.40 €
(-11.90%)
150
MLBONBonyf NV
15.90 €
(-11.67%)
105
ATOAtos SE
0.0022 €
(10.00%)
2.22B
BCPBanco Comercial Portugues SA
0.4802 €
(0.00%)
49.83M
ALVERVergnet
0.0017 €
(-5.56%)
18.84M
ALCYBCybergun
0.0002 €
(100.00%)
16.61M
INGAING Groep NV
15.538 €
(3.17%)
14.34M

Discusión

Ver feed completo
wadirum1 wadirum1 33 segundos hace
The audit has apparently taken about 10 years longer than expected, no?

Is there some point at which we should all just confront Eric on his BS? Or do you think it is for the best to just continue as if the decade of missed deadlines was all just some random sequence of events that
HHSE
Hosai Hosai 41 segundos hace
Even if you read it as needing another trial which is obv up for debate (also would be for FDA - EMA clearly not), it would still mean Anavex have better and more robust long term trial data (3-4 years) compared to any AD phase 2 previously done by a company.
Eli Lily jumped $15.3 billion (
AVXL
BarrellofHay BarrellofHay 51 segundos hace
Company alluded to a Phase 4.

"A phase 4 clinical trial, also known as a post-marketing surveillance trial, is a study that examines a drug's safety and effectiveness after it has been approved and is available for patients."

Key is that this is a study used afte
AVXL
gp22 gp22 55 segundos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
BottomBounce BottomBounce 56 segundos hace
$NIO Book Value Per Share (mrq) $12.43 Total Cash (mrq) $36.27B
NIO
I-Glow I-Glow 1 minuto hace
That is why you are underwater on Spooz because you believe anything Spooz posts on X as true and factual. LOLOL!

Spooz
@SpoozInc
2h
$SPZI The increase in the Authorized Shares is to secure potential acquisitions and to support the culmination of the commodity and
SPZI
gp22 gp22 1 minuto hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
Hi_Lo Hi_Lo 2 minutos hace
You haven't stopped anything and you never will
I'm not trying to stop anything. Unlike you and your lying pumps that helps and furthers this scam, I'm simply warning people here with documentation that this is a scam and that Jake P. Noch has a history of perpetrating huge frauds - including
BCAP
Strukture Strukture 2 minutos hace
VRME for the win today!
VRME
doc2016 doc2016 2 minutos hace
emPath ....thinking nvidia now hiring asic engineers in taiwan. i wonder why china wants more influence in taiwan? asics and fpga; asics and memristors, which remembering em state can go to tha switching /gate position..with soft fabric and software stacks and api's with the emPath information....
IONQ
martyDg martyDg 2 minutos hace
If I were a betting person, I would bet that mRESVIA and DCVax-L will be among the drugs that are approved by MHRA in January.


Who's going tell him he's about to be wrong? Maybe, try February, March, April and so on. 😝
NWBO
Zorax Zorax 2 minutos hace
Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?
UEEC
scortech scortech 2 minutos hace
I doubt same "Person". Buys are making MM's buy their shorts back
Did good slap an ask they'll lose their shorts and show their A$$
JMO.
CGAC
Investor2014 Investor2014 2 minutos hace
The ability of Anavex snatching defeat from the claws of victory is uncanny!
AVXL
BCCHoosier BCCHoosier 2 minutos hace
Spot on. We have used a few bullets already and going nowhere. If we do get bought out it will be for far less than any of us expected.
AVXL
jpike jpike 3 minutos hace
I now have the largest position in Pays that I have held in years. Looking forward to large gains in the next year or two on this one.
PAYS
peanutz peanutz 3 minutos hace
If you are depending on that it's ashame . You are in the wrong business.
IGPK
hedge_fun hedge_fun 3 minutos hace
Jeff if you recall, there was a promo…….

group that talked about the OS reduction through a Preferred offering about 2 years ago. It was when the pps ran up to around half a penny.

Then they dumped and stopped pumping.

But they mentioned it in a podcast
APRU
arachnodude arachnodude 3 minutos hace
You asked...

How many trolls like Slinger spend their days obsessively spreading cherry-picked, manipulated nonsense, ignoring facts, and attacking progress just to get a rise out of others? Unfortunately, the answer to that is: far too many.

🤣🤣🤣
KBLB
Zenos Arrow Zenos Arrow 3 minutos hace
I’m sure he’s still there Loc. Why would he leave – he’s still getting paid? The bigger question is, has he done enough to satisfy his six-month incentive metrics. If so, we should get an 8-K announcing that 500K more shares were granted via meeting these metrics. So, no communication forthcoming co
HDVY
Gator44 Gator44 3 minutos hace
https://ih.advfn.com/stock-market/NASDAQ/sana-biotechnology-SANA/stock-news/95237254/form-8-k-current-report
SANA
Mojocash Mojocash 3 minutos hace
Averaged down for a rainy day!
HLLK
linkvest linkvest 4 minutos hace
Eat those freakin awesome 5s up newbies. They are so cheap for a quality company that has so much on the horizon and about to explode any time now.
ASII
zab zab 4 minutos hace
https://www.yahoo.com/news/maga-republican-slammed-saying-california-003138819.html

Once again, Republicans from California, let's not pay for anything.

Su Consulta Reciente

EU
CLEX
Cumulex NV
TSXV
DPCC.P
Deal Pro Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados